Dana-Farber Leads Phase 3 Trials for Breast, Lung, and Bladder Cancer Unveiled at ESMO Congress 2025
Dana-Farber Cancer Institute’s groundbreaking research continues to shape the landscape of oncology as their experts present a series of pivotal ...
Tag: Phase 3 clinical trials
New Clinical Trials Confirm That Increased Semaglutide Dosages Safely Boost Weight Loss and Health Benefits in Adults with Obesity
In a groundbreaking development for the treatment of obesity, recent phase 3 clinical trials have demonstrated that a significantly higher ...
Moffitt to Unveil Plenary and Late-Breaking Findings on Blood, Melanoma, and Brain Metastases at ASCO 2025
TAMPA, Fla. – The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, set to convene from May 30 to ...
City of Hope Researchers Showcase Cutting-Edge Discoveries at AACR Annual Meeting
In a groundbreaking showcase at the AACR Annual Meeting 2025, the renowned City of Hope cancer research and treatment center ...
Dana-Farber Researchers to Showcase Pivotal Transplant and Cellular Therapy Findings at 2025 Tandem Meetings
Dana-Farber Researchers to Unveil Groundbreaking Studies at 2025 Tandem Meetings in Honolulu As the world’s foremost gathering in hematopoietic cell ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!